145 related articles for article (PubMed ID: 16626030)
1. Serological diagnosis of human polyomavirus infection.
Lundstig A; Dillner J
Adv Exp Med Biol; 2006; 577():96-101. PubMed ID: 16626030
[TBL] [Abstract][Full Text] [Related]
2. Seroepidemiology of the human polyomaviruses.
Stolt A; Sasnauskas K; Koskela P; Lehtinen M; Dillner J
J Gen Virol; 2003 Jun; 84(Pt 6):1499-1504. PubMed ID: 12771419
[TBL] [Abstract][Full Text] [Related]
3. Serological cross-reactivities between antibodies to simian virus 40, BK virus, and JC virus assessed by virus-like-particle-based enzyme immunoassays.
Viscidi RP; Rollison DE; Viscidi E; Clayman B; Rubalcaba E; Daniel R; Major EO; Shah KV
Clin Diagn Lab Immunol; 2003 Mar; 10(2):278-85. PubMed ID: 12626455
[TBL] [Abstract][Full Text] [Related]
4. Population-based study of antibody to the human polyomaviruses BKV and JCV and the simian polyomavirus SV40.
Knowles WA; Pipkin P; Andrews N; Vyse A; Minor P; Brown DW; Miller E
J Med Virol; 2003 Sep; 71(1):115-23. PubMed ID: 12858417
[TBL] [Abstract][Full Text] [Related]
5. Serological cross reactivity between polyomavirus capsids.
Viscidi RP; Clayman B
Adv Exp Med Biol; 2006; 577():73-84. PubMed ID: 16626028
[TBL] [Abstract][Full Text] [Related]
6. Prevalence and stability of antibodies to the BK and JC polyomaviruses: a long-term longitudinal study of Australians.
Antonsson A; Green AC; Mallitt KA; O'Rourke PK; Pawlita M; Waterboer T; Neale RE
J Gen Virol; 2010 Jul; 91(Pt 7):1849-53. PubMed ID: 20219899
[TBL] [Abstract][Full Text] [Related]
7. Prevalence and stability of human serum antibodies to simian virus 40 VP1 virus-like particles.
Lundstig A; Eliasson L; Lehtinen M; Sasnauskas K; Koskela P; Dillner J
J Gen Virol; 2005 Jun; 86(Pt 6):1703-1708. PubMed ID: 15914848
[TBL] [Abstract][Full Text] [Related]
8. Comparison of antibody titers determined by hemagglutination inhibition and enzyme immunoassay for JC virus and BK virus.
Hamilton RS; Gravell M; Major EO
J Clin Microbiol; 2000 Jan; 38(1):105-9. PubMed ID: 10618072
[TBL] [Abstract][Full Text] [Related]
9. Seroprevalence rates of BKV, JCV, and MCPyV polyomaviruses in the general Czech Republic population.
Sroller V; Hamšíková E; Ludvíková V; Vochozková P; Kojzarová M; Fraiberk M; Saláková M; Morávková A; Forstová J; Němečková S
J Med Virol; 2014 Sep; 86(9):1560-8. PubMed ID: 24214630
[TBL] [Abstract][Full Text] [Related]
10. Simian virus 40 (SV40) and human cancer: a review of the serological data.
Shah KV; Galloway DA; Knowles WA; Viscidi RP
Rev Med Virol; 2004; 14(4):231-9. PubMed ID: 15248251
[TBL] [Abstract][Full Text] [Related]
11. Discovery and epidemiology of the human polyomaviruses BK virus (BKV) and JC virus (JCV).
Knowles WA
Adv Exp Med Biol; 2006; 577():19-45. PubMed ID: 16626025
[TBL] [Abstract][Full Text] [Related]
12. Interplay of cellular and humoral immune responses against BK virus in kidney transplant recipients with polyomavirus nephropathy.
Chen Y; Trofe J; Gordon J; Du Pasquier RA; Roy-Chaudhury P; Kuroda MJ; Woodle ES; Khalili K; Koralnik IJ
J Virol; 2006 Apr; 80(7):3495-505. PubMed ID: 16537617
[TBL] [Abstract][Full Text] [Related]
13. Age-specific seroprevalence of Merkel cell polyomavirus, BK virus, and JC virus.
Viscidi RP; Rollison DE; Sondak VK; Silver B; Messina JL; Giuliano AR; Fulp W; Ajidahun A; Rivanera D
Clin Vaccine Immunol; 2011 Oct; 18(10):1737-43. PubMed ID: 21880855
[TBL] [Abstract][Full Text] [Related]
14. Generation of virus-like particles consisting of the major capsid protein VP1 of goose hemorrhagic polyomavirus and their application in serological tests.
Zielonka A; Gedvilaite A; Ulrich R; Lüschow D; Sasnauskas K; Müller H; Johne R
Virus Res; 2006 Sep; 120(1-2):128-37. PubMed ID: 16780983
[TBL] [Abstract][Full Text] [Related]
15. Lack of serologic evidence for prevalent simian virus 40 infection in humans.
Carter JJ; Madeleine MM; Wipf GC; Garcea RL; Pipkin PA; Minor PD; Galloway DA
J Natl Cancer Inst; 2003 Oct; 95(20):1522-30. PubMed ID: 14559874
[TBL] [Abstract][Full Text] [Related]
16. Prediagnostic circulating antibodies to JC and BK human polyomaviruses and risk of non-Hodgkin lymphoma.
Rollison DE; Engels EA; Halsey NA; Shah KV; Viscidi RP; Helzlsouer KJ
Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):543-50. PubMed ID: 16537714
[TBL] [Abstract][Full Text] [Related]
17. Seroprevalence rates of HPyV6, HPyV7, TSPyV, HPyV9, MWPyV and KIPyV polyomaviruses among the healthy blood donors.
Šroller V; Hamšíková E; Ludvíková V; Musil J; Němečková Š; Saláková M
J Med Virol; 2016 Jul; 88(7):1254-61. PubMed ID: 26630080
[TBL] [Abstract][Full Text] [Related]
18. Prediagnostic circulating polyomavirus antibody levels and risk of non-Hodgkin lymphoma.
Teras LR; Rollison DE; Pawlita M; Michel A; Blase JL; Willhauck-Fleckenstein M; Gapstur SM
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):477-80. PubMed ID: 25488906
[TBL] [Abstract][Full Text] [Related]
19. Prevalence and stability of antibodies to thirteen polyomaviruses and association with cutaneous squamous cell carcinoma: A population-based study.
Antonsson A; Neale RE; O'Rourke P; Wockner L; Michel A; Pawlita M; Waterboer T; Green AC
J Clin Virol; 2018 Apr; 101():34-37. PubMed ID: 29414185
[TBL] [Abstract][Full Text] [Related]
20. Seroepidemiology of human polyomaviruses.
Kean JM; Rao S; Wang M; Garcea RL
PLoS Pathog; 2009 Mar; 5(3):e1000363. PubMed ID: 19325891
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
